Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 51Rectal Neoplasms 28Colonic Neoplasms 16Stomach Neoplasms 14Carcinoma, Hepatocellular 14Neoplasm Metastasis 9Adenocarcinoma Of Esophagus 7Esophageal Neoplasms 6Neoplasms 5Cholangiocarcinoma 5Recurrence 3Pancreatic Neoplasms 3Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Adenocarcinoma 3Ovarian Neoplasms 2Liver Neoplasms 2Intestinal Neoplasms 2Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Cirrhosis, Familial, with Pulmonary Hypertension 2Biliary Tract Neoplasms 2Peritoneal Neoplasms 1Pancreatic Adenocarcinoma 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Neurotoxicity Syndromes 1Metastatic Colorectal Adenocarcinoma 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Locally Advanced Colorectal Carcinoma 1Intestinal Diseases 1

Interventions

Capecitabine 2irinotecan sucrosofate 1Immunotherapy 1Folfox protocol 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Advanced Rectal Cancer × Folfox protocol × Clear all
NCT03781323 2026-06-04

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

University of Rochester

Phase 2 Active not recruiting
12 enrolled 9 charts
Gastrointestinal

Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡